AngioDynamics Port Catheter Lawsuit
- Last Updated: December 18th, 2024
Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
Legally Reviewed
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
Fact-Checked
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Key takeaways:
- The AngioDynamics Port Catheter Lawsuit was consolidated into MDL No. 3125 in October 2024, with claims against AngioDynamics and Navilyst for defective devices causing severe health issues.
- Patients reported serious complications like blood clots, device migration, infections, and the need for premature surgeries, linked to the devices' barium sulfate content.
- Eligible patients must have experienced complications from an AngioDynamics port catheter, with potential compensation covering medical expenses, lost wages, and pain and suffering.
Overview of the AngioDynamics Port Catheter Lawsuit
The AngioDynamics Port Catheter Lawsuit involves numerous patients filing claims against AngioDynamics and Navilyst for issues related to the product design, manufacturing, and testing of their implantable port catheter devices, posing serious health risks.
AngioDynamics port catheter devices are often used to deliver medications directly into a patient’s bloodstream (often for chemotherapy or other treatments), and are prone to degradation and fracture, causing defects that can lead to severe complications
On this page, we’ll provide an overview of the AngioDynamics port catheter lawsuit, eligibility for filing an AngioDynamics port catheter lawsuit, AngioDynamics port catheter claims for defective devices, and much more.
AngioDynamics Port Catheter Linked to Serious Injuries
The AngioDynamics Port Catheter lawsuits have been consolidated into a Multidistrict Litigation (MDL) in the U.S. District Court for the Southern District of California in October 2024.
Patients who received AngioDynamics port catheters have reported experiencing serious complications, such as:
- Blood clots (thrombosis)
- Device migration
- Catheter fracture
- Infections
- Chronic pain
- Premature removal
- Replacement surgeries
- Other serious complications and injuries
As the MDL progresses, it will handle common issues related to the design, development, testing, manufacture, marketing, and sale of the devices, and the warnings provided with them.
If you or someone you love has experienced serious complications after receiving an AngioDynamics port catheter, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine your eligibility to join others filing in the AngioDynamics Port Catheter MDL today.
Table of Contents
Lawsuit Updates
-
December 2024 Updates:
December 13, 2024
A Minnesota woman has filed a lawsuit against AngioDynamics Inc. and Navilyst Medical Inc., alleging that the AngioDynamics SmartPort catheter caused a severe infection that required surgical removal.
The lawsuit, filed on December 6, 2024, in the U.S. District Court for the District of Minnesota, is among a growing number of cases asserting defects in the design and safety of the implantable port catheter.
Case Details:
- Device: AngioDynamics SmartPort, an implantable catheter used for administering chemotherapy and other treatments.
- Timeline: The plaintiff received the device in May 2022. By December 2022, she experienced pain and swelling, initially misdiagnosed as a blood clot. Subsequently, a Staphylococcus epidermis infection was detected, necessitating the device’s removal on December 23, 2022.
- Allegations: The lawsuit claims the catheter’s polyurethane material, which contains high levels of barium sulfate, is susceptible to microfractures that can cause infections and other complications. The plaintiff asserts that the manufacturer failed to provide adequate warnings about these risks.
The plaintiff is seeking compensatory damages to cover her injuries and related expenses.
This lawsuit is likely to be included in the AngioDynamics SmartPort multidistrict litigation (MDL) established in October 2024 in the Southern District of California, overseen by Judge Jinsook Ohta.
If an AngioDynamics port catheter has caused you or a loved one to experience serious health complications such as blood clots, deep vein thrombosis (DVT), or other severe issues, you may be eligible to file a lawsuit.
Contact TruLaw for a free consultation to learn more about potential compensation.
You can also use the chatbot on this page to instantly determine if you qualify for the AngioDynamics Port Catheter Lawsuit.
December 6, 2024
AngioDynamics Inc. and its subsidiary, Navilyst Medical Inc., are facing a lawsuit in Georgia federal court over claims that their Vortex Port device is defective and poses serious risks to patients.
The plaintiff alleges the device caused a severe infection that required hospitalization and removal after being implanted during chemotherapy for lymphoma.
The lawsuit asserts that the Vortex Port’s polyurethane catheter, combined with barium sulfate, results in surface irregularities that promote biofilm formation, leading to infections and sepsis.
It is further alleged that the device is prone to fracturing, with broken fragments potentially migrating to vital organs, increasing the risk of severe complications, such as hemorrhage and death.
Despite numerous adverse event reports, the companies are accused of failing to address these defects or warn doctors and patients, instead marketing the device as safe.
The suit also emphasizes that the Vortex Port’s design complicates safe removal, posing additional risks to patients in cases of device failure or injury.
The plaintiff is seeking compensation for medical expenses, general damages, and legal fees.
The case, Jordan v. AngioDynamics Inc. et al., highlights ongoing concerns regarding the safety and accountability of medical devices.
If an AngioDynamics port catheter has caused you or a loved one to experience serious health complications such as blood clots, deep vein thrombosis (DVT), or other severe issues, you may be eligible to file a lawsuit.
Contact TruLaw for a free consultation to learn more about potential compensation.
You can also use the chatbot on this page to instantly determine if you qualify for the AngioDynamics Port Catheter Lawsuit.
December 2, 2024
The AngioDynamics Port Catheter lawsuit addresses claims that the medical device, designed for long-term venous access, has led to complications such as infections, device fractures, and blood clots.
Plaintiffs assert that AngioDynamics failed to provide sufficient warnings about these risks.
In November, 62 cases were filed, rising to 72 by December with the addition of 10 new claims.
This increase highlights growing awareness of the potential risks linked to the device.
Complications associated with the AngioDynamics Port Catheter can result in serious health problems, often requiring medical intervention and significantly affecting the well-being of patients.
If an AngioDynamics port catheter has caused you or a loved one to experience serious health complications such as blood clots, deep vein thrombosis (DVT), or other severe issues, you may be eligible to file a lawsuit.
Contact TruLaw for a free consultation to learn more about potential compensation.
You can also use the chatbot on this page to instantly determine if you qualify for the AngioDynamics Port Catheter Lawsuit.
-
November 2024 Updates:
The AngioDynamics Port Catheter Lawsuit is currently underway, with a multidistrict litigation (MDL) established to manage claims related to this medical device.
The lawsuit centers on allegations that the AngioDynamics port catheter, designed for long-term venous access, has caused severe complications such as infections, fractures, and blockages.
Plaintiffs claim that AngioDynamics failed to provide adequate warnings about these risks, resulting in serious health issues for patients relying on the device.
As of October, 50 cases had been filed, with the number rising to 62 by November—an increase of 12 cases.
This growth highlights increasing awareness among affected patients and healthcare providers about the potential dangers linked to the device.
AngioDynamics port catheters have been associated with significant health risks, including life-threatening infections and structural fractures, posing serious challenges for patients requiring dependable, long-term venous access.
If an AngioDynamics port catheter has caused you or a loved one to experience serious health complications such as blood clots, deep vein thrombosis (DVT), or other severe issues, you may be eligible to file a lawsuit.
Contact TruLaw for a free consultation to learn more about potential compensation.
You can also use the chatbot on this page to instantly determine if you qualify for the AngioDynamics Port Catheter Lawsuit.
-
October 2024 Updates:
The U.S. Judicial Panel on Multidistrict Litigation (JPML) has recently consolidated all AngioDynamics Port Catheter Lawsuits into a multidistrict litigation (MDL) in the U.S. District Court for the Southern District of California, under the supervision of Judge Jinsook Ohta.
This MDL includes over 50 lawsuits filed nationwide, with additional cases expected to join.
Plaintiffs argue that AngioDynamics’ port catheters, commonly used for long-term medical treatments, are defectively designed and pose serious health risks, including fractures, blood clots, and infections.
According to the lawsuits, the catheter’s design makes it susceptible to structural degradation and fractures, potentially leading to device failure inside the body.
Plaintiffs also claim that the catheter’s breakdown enables fibrinous blood products to accumulate, increasing the risk of fractures and severe infections.
The MDL aims to streamline pretrial proceedings, reduce duplicate discovery efforts, and ensure consistent rulings across cases.
Judge Ohta is expected to appoint lead attorneys to represent the plaintiffs, overseeing discovery processes and bellwether trials.
These initial trials will focus on selected cases to test jury reactions to critical evidence, which could influence future settlement negotiations.
If an AngioDynamics port catheter has caused you or a loved one to experience serious health complications such as blood clots, deep vein thrombosis (DVT), or other severe issues, you may be eligible to file a lawsuit.
Contact TruLaw for a free consultation to learn more about potential compensation.
You can also use the chatbot on this page to instantly determine if you qualify for the AngioDynamics Port Catheter Lawsuit.
AngioDynamics Port Catheter Claims for Defective Devices
The AngioDynamics Port Catheter Products Liability Litigation has been consolidated into a Multidistrict Litigation (MDL No. 3125) in the U.S. District Court for the Southern District of California.
This centralization, established on October 3, 2024, by the United States Judicial Panel on Multidistrict Litigation, aims to streamline the legal process for numerous similar cases across the country.
Allegations Against Device Manufacturers
The primary defendants in this litigation are AngioDynamics, Inc., and Navilyst Medical, Inc., the manufacturers and distributors of the implantable port catheter devices.
The key allegations against these companies include:
- Defective design of port catheter devices
- Use of excessive concentrations of barium sulfate in catheter manufacturing
- Failure to adequately warn healthcare providers and patients of potential risks
- Insufficient pre-market testing to identify potential complications
- Negligence in the production and quality control of the devices
Plaintiffs argue that these alleged shortcomings have led to serious health complications for patients who received the AngioDynamics port catheters.
Individual Injury Claims Reported
The consolidation of these cases into an MDL allows for more efficient handling of common factual and legal issues while still preserving the individual nature of each plaintiff’s claim.
These cases report various injuries that include, but are not limited to:
- Catheter fracture and migration
- Severe infections at the implant site
- Formation of blood clots (thrombosis)
- Perforation of blood vessels or organs
- Need for additional surgeries to remove or replace the device
- Chronic pain and discomfort
As the litigation progresses, it is expected that more patients may come forward with similar allegations, potentially expanding the scope of the MDL.
AngioDynamics Port Catheter Products: Reported Health Complications
The health complications reportedly associated with AngioDynamics port catheters have raised serious concerns within the medical community and among patients.
These issues range from immediate post-implantation problems to long-term health risks, potentially affecting the quality of life and overall health outcomes for patients who received these devices.
Risks of Medical Device: Barium Sulfate
AngioDynamics port catheters contain barium sulfate, a substance used to make the devices visible on X-rays.
While barium sulfate is commonly used in medical imaging, its presence in implantable devices has raised concerns.
Patients have reported the following adverse reactions:
- Allergic reactions:
- Inflammation at the implant site:
- Formation of granulomas (small areas of inflammation):
- Potential long-term toxicity concerns:
Legal experts are investigating whether AngioDynamics performed adequate research or disclosed the potential risks associated with long-term exposure to barium sulfate in implanted devices.
Research Indicates Elevated Thrombosis Risk
One of the most significant concerns surrounding AngioDynamics port catheters is the reportedly increased risk of thrombosis or blood clot formation.
Several studies have suggested that these devices may be associated with a higher incidence of catheter-related thrombosis compared to other similar products on the market.
Key points from recent research include:
- Incidence and Clinical Significance:
- Symptomatic thromboembolic complications occur in ≤5% of oncology patients with CVCs.
- Asymptomatic CVC-related thrombi are common; clinical significance is unclear.
- Risk Factors:
- Increased risk from thrombophilic disorders (e.g., factor V Leiden mutation).
- Other risk factors include thrombogenic material, larger diameter, more lumens, malposition, left-side placement, multiple insertions, previous CVC, venous obstruction, prothrombotic agents, infections, and lumen occlusion.
- Thromboprophylaxis:
- Routine low-dose warfarin/heparin was not beneficial for general oncology patients.
- Thromboprophylaxis may be safe for high-risk patients.
- Diagnosis:
- Duplex ultrasound detects thrombi in jugular, axillary, subclavian, and arm veins.
- Contrast venography is needed for unclear duplex results and deep vein evaluation.
- Treatment:
- Anticoagulation, with/without catheter removal, for DVT or pulmonary embolism without contraindications.
- Catheter removal alone may suffice if the bleeding risk is high.
- Thrombolytics were used based on limited experience and lower-extremity DVT practices.
- Future Research Needs:
- Additional research is required to find safe anticoagulants, treatment durations, and venous access strategies for cancer patients with catheter thrombosis.
Thrombosis can lead to serious complications, including pulmonary embolism, stroke, need for anticoagulation therapy, and catheter malfunction requiring removal and replacement.
The MDL proceedings are expected to examine the scientific evidence regarding thrombosis risk and determine whether AngioDynamics failed in its duty to warn about this potential complication.
Eligibility to File a AngioDynamics Port Catheter Lawsuit
To be eligible for inclusion in the AngioDynamics Port Catheter MDL, plaintiffs must have had small medical devices implanted and subsequently suffered complications.
While the exact eligibility requirements may evolve as the litigation progresses, there are general factors that typically determine a patient’s ability to file a claim related to these defective medical devices.
Collecting Evidence for Port Catheter Legal Claims
Gathering strong evidence is important for building a solid case within the AngioDynamics Port Catheter MDL.
Patients and their legal representatives should focus on collecting comprehensive documentation to support their claims.
Key evidence may include:
- Medical records detailing the implantation of the AngioDynamics port catheter
- Documentation of complications or adverse events, such as catheter migration or deep vein thrombosis
- Imaging studies showing device degradation, fracture, or impact on blood flow
- Records of surgical interventions necessitated by device complications
- Expert medical opinions linking the patient’s injuries to the port catheter
Plaintiffs’ attorneys will likely work closely with medical experts to analyze this evidence and establish a causal link between the AngioDynamics port catheter and the reported injuries.
Evaluating Damages in Port Catheter Cases
The assessment of damages in AngioDynamics port catheter cases involves considering various factors related to the impact of device complications on patients’ lives.
These complications often require repeated needle sticks for treatment or diagnosis, adding to the patient’s discomfort and potential trauma.
Potential damages that may be claimed in the AngioDynamics Port Catheter MDL include:
- Medical expenses for additional treatments or surgeries
- Lost wages due to extended recovery periods or inability to work
- Pain and suffering caused by device complications
- Reduced quality of life resulting from ongoing health issues
- Emotional distress related to unexpected medical complications
As the litigation progresses, the court may provide more specific guidelines for evaluating and presenting damage claims within the MDL framework, particularly focusing on the unique challenges posed by these implanted devices.
Frequently Asked Questions
-
What is the AngioDynamics Port Catheter MDL lawsuit about?
The AngioDynamics Port Catheter MDL involves patients filing claims against AngioDynamics and Navilyst for issues related to defective port catheter devices that can cause serious health complications.
The lawsuit has been consolidated in the U.S. District Court for the Southern District of California to address common issues regarding design, manufacturing, and inadequate warnings.
-
What are the main health complications associated with AngioDynamics Port Catheters?
AngioDynamics Port Catheters have been linked to serious complications including blood clots, device migration, catheter fracture, and severe infections.
These complications often require additional surgeries and can lead to chronic pain and other long-term health issues.
-
What is the concern about barium sulfate in AngioDynamics Port Catheters?
Barium sulfate is used in the catheters to make them visible on X-rays, but there are concerns about excessive concentrations causing adverse reactions and long-term toxicity.
Patients have reported inflammation, allergic reactions, and the formation of granulomas at the implant site.
-
Who is eligible to file a claim in the AngioDynamics Port Catheter MDL?
Patients who received an AngioDynamics port catheter and subsequently experienced complications such as device failure, infections, or blood clots may be eligible to file a claim.
Eligible plaintiffs must provide comprehensive medical documentation proving their injuries were caused by the device.
-
What types of compensation can plaintiffs seek in the Port Catheter lawsuit?
Plaintiffs can seek compensation for medical expenses, lost wages, pain and suffering, and other damages related to complications from the device.
The compensation amount typically depends on factors such as the severity of complications and impact on quality of life.
-
What evidence is needed to support an AngioDynamics Port Catheter claim?
Key evidence includes medical records documenting the device implantation and any subsequent complications or adverse events.
Additional supporting documentation should include imaging studies, surgical records, and expert medical opinions linking injuries to the port catheter.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
